Skip to content
Screener

Teleflex TFX Q2 2026 earnings

Reported August 6, 2026 · Before market open

Revenue$570.3MBeat by $10.7M
EPS$1.76Beat by $0.48
Revenue estimate$559.6M
EPS estimate$1.28
“We delivered a strong second quarter, led by excellent performance in our Vascular and Surgical businesses, while continuing to take decisive actions to strengthen the company for the future. The completion of the OEM divestiture marks a pivotal step in our transformation, enabling greater focus on our core businesses, a stronger balance sheet, and increased financial flexibility to further reduce debt, return capital to shareholders, and invest in the opportunities that will drive long-term growth. We also made meaningful progress advancing our innovation pipeline, including important milestones for Freesolve and the Food and Drug Administration approval for EZPLAZ, reinforcing our commitment to bringing differentiated solutions to the market.”
Jason Weidman

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$565.4M
EPS estimate$1.92

Financials

Q2 2026

Income statement

See full
Revenue$570.3M+28.9%
Gross profit$331.7M+24.8%
Operating income$72.8M-20.1%
Net income$99.7M-18.7%
EPS (diluted)$2.28-17.7%

Balance sheet

See full
Cash & equivalents$316.9M+23.5%
Total debt$3.0B+49.5%
Total equity$2.9B-31.5%
Total assets$6.8B-8.0%

Cash flow

See full
Operating cash flow$91.9M+348%
CapEx$14.0M-49.5%
Free cash flow$77.9M+220%

Valuation & ratios

Valuation

as of 09/16/26
See full
Market cap$5.47B-1.7%
Enterprise value$8.13B+11.4%
P/S2.4×-0.8×

Profitability

See full
Gross margin46.7%-4.5pp
Operating margin2%-14.9pp
Net margin-45.8%-56.9pp

Returns & leverage

See full
Return on equity-28.9%-33.2pp
Debt / equity1×+0.6×
Current ratio2.6×+0.2×

Segments

By segment

See full
Americas$348.8M+14.4%
EMEA$145.5M+62.0%
Asia$76.0M+59.5%

By product

See full
Vascular$246.3M+9.0%
Interventional$211.9M+86.1%
Surgical$112.1M+9.1%

FAQ

When did Teleflex report Q2 2026 earnings?
Teleflex (TFX) reported Q2 2026 earnings on August 6, 2026 before market open.
What were Teleflex's Q2 2026 revenue and EPS?
Teleflex reported revenue of $570.3M and eps of $1.76 for Q2 2026.
Did Teleflex beat estimates in Q2 2026?
Revenue beat the consensus estimate of $559.6M by $10.7M. EPS beat the consensus estimate of $1.28 by $0.48.
How did Teleflex's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 27.0% from $780.9M a year earlier and eps declined 52.8% from $3.73.
Where can I find Teleflex's Q2 2026 SEC filings?
You can read the 8-K earnings release (0000096943-26-000084) and the 10-Q periodic report (0000096943-26-000095) directly on SEC EDGAR. The filing index links above go to sec.gov.